Onco-Innovations Limited (CVE:ONCO)

PRESS RELEASE

published on 07/05/2025 at 00:00, 10 months 4 days ago

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Onco-Innovations partners with Nucro-Technics for preclinical studies on PNKP inhibitor, critical step towards human trials. Strategic collaboration with GLP and GMP experienced CRO

Clinical Trials Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
BRIEF

published on 07/03/2025 at 00:35, 10 months 6 days ago

Onco-Innovations Reveals Strategic Developments in Investor Call

Artificial Intelligence Cancer Treatment Strategic Milestones Onco-Innovations PNKP Inhibitor
BRIEF

published on 07/03/2025 at 00:35, 10 months 6 days ago

Onco-Innovations dévoile ses développements stratégiques lors d'une conférence téléphonique avec les investisseurs

Intelligence Artificielle Traitement Du Cancer Étapes Stratégiques Onco-Innovations Inhibiteur De PNKP
PRESS RELEASE

published on 07/03/2025 at 00:30, 10 months 6 days ago

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
Onco-Innovations updates strategic roadmap for cancer treatment innovation, highlighting AI partnerships and research collaborations

Cancer Treatment Strategic Roadmap AI Partnerships Onco-Innovations Research Collaborations
BRIEF

published on 06/28/2025 at 00:05, 10 months 11 days ago

Onco-Innovations and AstraZeneca Collaboration in AI-Oncology Consortium

Cancer Research PROmAI Consortium AI Oncology AstraZeneca Partnership Causal AI
BRIEF

published on 06/28/2025 at 00:05, 10 months 11 days ago

Collaboration entre Onco-Innovations et AstraZeneca au sein du consortium IA-Oncologie

Recherche Sur Le Cancer Oncologie IA Consortium PROmAI Partenariat Avec AstraZeneca IA Causale
PRESS RELEASE

published on 06/28/2025 at 00:00, 10 months 11 days ago

Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
Onco-Innovations' Inka Health receives Expression of Interest from AstraZeneca to join PROmAI Consortium, advancing AI solutions in oncology. AstraZeneca's involvement reinforces the Consortium's mission of enhancing predictive cancer research

Oncology AstraZeneca Onco-Innovations Inka Health PROmAI Consortium
BRIEF

published on 06/26/2025 at 00:05, 10 months 13 days ago

Onco-Innovations Announces Special Investors' Conference Call

Cancer Research Onco-Innovations Thomas O'Shaughnessy July 2025 Investors' Conference
BRIEF

published on 06/26/2025 at 00:05, 10 months 13 days ago

Onco-Innovations annonce une conférence téléphonique spéciale pour les investisseurs

Conférence Des Investisseurs Recherche Sur Le Cancer Onco-Innovations Thomas O'Shaughnessy Juillet 2025
PRESS RELEASE

published on 06/26/2025 at 00:00, 10 months 13 days ago

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
Onco-Innovations Limited announces special investor conference call with CEO Thomas O'Shaughnessy on July 2, 2025. Join at link.meetingpanel.com, or via toll-free number

Patented Technology Cancer Research Investor Conference Call Onco-Innovations Limited Thomas O'Shaughnessy

Published on 05/09/2026 at 01:55, 12 hours 7 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 12 hours 22 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 12 hours 32 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 14 hours 2 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 15 hours 1 minute ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 17 hours 24 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 18 hours 49 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 19 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 19 hours 33 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 19 hours 33 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 18 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 18 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 18 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 18 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 19 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News